NEPH · Nephros Inc
Market Cap
$45.94M
Shares
10.86M
Volume · Oct 5
17.54K
Avg daily vol (3M)
22.32K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$3.67
Open$3.71
Day$3.63–3.89
52W close$2.78–5.79
Avg vol 30d27K
Short int46K · 0.4% float · 2.1d
Short vol5%
Last earningsAug 6, 2026
DataJan 2020–Oct 2026
Filing10-Q · Aug 10
Up next
Next earnings call
Oct 9, 2026
Est · unconfirmed
· in 1 wks
filed Aug 10, 2026
call held Aug 6, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
-20.9%
Trailing year
Short interest
0.4%
Latest settlement · 2.1 days to cover
AI Brief
Q2 FY26 earnings call · Aug 6, 2026
Q2 FY26
TL;DR. Nephros reported record Q2 2026 net revenue of $6.0 million, up 36% year-over-year, with core programmatic revenue up 27% and service revenue nearly tripling; however, reported gross margin benefited from a one-time ~$0.6 million IEEPA tariff refund and operating cash flow declined versus the prior-year quarter.
Bullish
- + Record quarterly net revenue of $6.0 million, up 36% year-over-year.
- + Core programmatic revenue grew approximately 27% year-over-year.
- + Service revenue nearly tripled year-over-year.
- + Net income and adjusted EBITDA roughly quadrupled and roughly tripled, respectively, year-over-year.
- + First-half 2026 revenue grew 21% to $11.2 million with debt-free balance sheet and ~$4.7 million in cash.
Bearish
- − Q2 operating cash flow declined $313,000 year-over-year to $681,000.
- − Underlying gross margin remains pressured by tariffs, weaker dollar, higher shipping, and lower-margin service/commercial mix.
- − First-half 2026 gross margin slipped to ~63% from ~64% as service/commercial mix offset the tariff refund benefit.
- − Q2 results were inflated by a one-time ~$0.6 million IEEPA tariff refund that boosted gross margin by roughly nine percentage points.
- − Six-month operating cash flow swung to a $990,000 use of cash from $1.3 million provided a year earlier.
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Sell
Momentum
Neutral
Sentiment
Neutral
Fundamentals
Excellent
Quant / Vol
Very High
Market backdrop
VIX 15.3 · calm
Equity put/call 0.58
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−4%
below
Price vs 50-day avg
−11%
below
RSI (14)
37
neutral
MACD trend
Negative
52-week position
30%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−12%
trailing
6-month return
+26%
trailing
YTD return
−25%
this year
Relative strength
+14%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $4 › 200d $4 — 50d above 200d
Institutional flow
Accumulating
+22% holders QoQ · +7 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.43% of float · ▲ +13.3% MoM · 2.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
33 holders — mid 3-yr range
Squeeze score
37
low risk · 0–100
Fundamentals
Revenue growth
+33%
Y/Y
Gross margin
62%
expanding
EPS growth
+1000%
Y/Y
Free cash flow
$1.5M
Valuation
P/E 26.4
rich
Balance sheet
$3.6M
net cash
Quant / Vol
risk profile
Volatility
86%
annualized · 1-yr
Max drawdown
−52%
past year
ATR
8.2%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed May 6, 2021
Gross margins
· future
55% – 60%
Guided vs delivered
· last 1 settled
Revenue
2022
guided $13M – $13.5M
$9.98M
Miss −24.7%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−4%
Neutral
Price vs 50-day avg
−11%
Bearish
RSI (14)
37
Neutral
MACD trend
Negative
Bearish
52-week position
30%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $4 › 200d $4 — 50d above 200d
Institutional flow
Accumulating
+22% holders QoQ · +7 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.43% of float · ▲ +13.3% MoM · 2.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
33 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $3
Now $4 · 30%
Range high $6
vs 200-day avg -4%
vs 50-day avg -11%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | 1.3M | Q2 2026 | — |
| Core programmatic revenue growth | 25% | Six Months Ended June 30, 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Instruments & Supplies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
NEPH
this stock
Nephros Inc
|
$45.94M | -24.8% | +32.7% | 26.4 | 0.4% |
|
ISRG
Intuitive Surgical Inc
|
$143.14B | -30.8% | +20.5% | 46.5 | 2.3% |
|
BDX
Becton Dickinson & Co
|
$49.57B | — | +8.2% | — | 4.2% |
|
MDLN
Medline Inc.
|
$45.62B | -15.2% | +11.5% | — | 3.1% |
|
RMD
Resmed Inc
|
$32.02B | -9.1% | +13.4% | 21.3 | 9.8% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| NEPH | -13.2% | -12.2% | +26.1% | -1.1% | -24.8% |
| SPY | -0.2% | -0.5% | +12.2% | +0.9% | +12.9% |
| vs SPY | -13.0% | -11.7% | +13.9% | -2.0% | -37.7% |